ARTICLE | Distillery Therapeutics
GHRH agonist to protect retinal ganglion cells from optic neuropathy
July 30, 2021 6:02 PM UTC
DISEASE CATEGORY: Ophthalmic
INDICATION: Optic neuropathy...
BCIQ Target Profiles
Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
DISEASE CATEGORY: Ophthalmic
INDICATION: Optic neuropathy...
BCIQ Target Profiles